Fundraising Fox
AmyriAD
2 known investors
Find your way into AmyriAD
Sign up to see every warm intro you have to AmyriAD
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AmyriAD team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Amyriad Therapeutics develops disease-modifying therapies for Alzheimer's disease, with a lead candidate called Ismidenon that employs novel cholinergic enhancement mechanisms. The company is led by neuroscientists and clinical experts focused on restoring cognitive function in aging-related neurodegeneration.
Founders & leadership
AK
Anil K. RattyCEO & FounderAnil K. Ratty is a biochemist and molecular biologist who has held research positions at institutions including Buffalo General Hospital, Roswell Park Cancer Institute, and the Institute of Molecular and Cell Biology in Singapore. He previously served as Regional Director for Asia at a US biotech company and has founded or co-founded multiple biotech and IT ventures before launching Amyriad Therapeutics, which develops cognitive restoration therapies for Alzheimer's disease.
Investors · 2
In the news
Frequently asked questions
- What does AmyriAD do?
- Amyriad Therapeutics develops disease-modifying therapies for Alzheimer's disease, with a lead candidate called Ismidenon that employs novel cholinergic enhancement mechanisms. The company is led by neuroscientists and clinical experts focused on restoring cognitive function in aging-related neurodegeneration.
- Who founded AmyriAD?
- AmyriAD was founded by Anil K. Ratty.
- Who are AmyriAD's investors?
- AmyriAD's investors include Elevat3 Capital, What If Ventures.